BAY1436032

BAY1436032 · Bayer

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BAY1436032, covering 2024-12-18 to 2024-12-18. Get the full timeline:

Most recent: Clinical Trial Update: Phase I Study of BAY1436032 in IDH1-mutant Advanced Solid Tumors [Phase 1]